tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Hurabielle C et al. Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's disease. 2016 J Dermatolog Treat pmid:25909366
Muduma G et al. Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant. 2016 PLoS ONE pmid:27812112
Prókai Á et al. Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts. 2016 Transplantation pmid:26502369
Unver Dogan N et al. Investigation of developmental toxicity and teratogenicity of cyclosporine A, tacrolimus and their combinations with prednisolone. 2016 Regul. Toxicol. Pharmacol. pmid:26993750
Garcovich S et al. First report of hereditary Christ-Siemens-Touraine syndrome and non-segmental vitiligo association in a young adult: contraindication for vitiligo treatment. 2016 J Eur Acad Dermatol Venereol pmid:25339629
Ferjani H et al. Combination of tacrolimus and mycophenolate mofetil induces oxidative stress and genotoxicity in spleen and bone marrow of Wistar rats. 2016 Mutat. Res. pmid:27776691
Deng S et al. Mechanism of tacrolimus-induced chronic renal fibrosis following transplantation is regulated by ox-LDL and its receptor, LOX-1. 2016 Mol Med Rep pmid:27633115
Fathy M et al. Impact of CYP3A5 and MDR-1 gene polymorphisms on the dose and level of tacrolimus among living-donor liver transplanted patients: single center experience. 2016 Biomarkers pmid:26856709
Størset E et al. Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience. 2016 Nephrology (Carlton) pmid:26854648
Novosel MK and Bistrup C Discontinuation of steroids in ABO-incompatible renal transplantation. 2016 Transpl. Int. pmid:26706618
Suh SW et al. Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients. 2016 J. Korean Med. Sci. pmid:27709847
Yamamoto T et al. Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study. 2016 Aliment. Pharmacol. Ther. pmid:26762838
Witt LJ et al. Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. 2016 Pulm Pharmacol Ther pmid:26762710
Dayal S et al. Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy. 2016 Pediatr Dermatol pmid:27699846
Bakardzhiev I et al. Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem. 2016 Wien Med Wochenschr pmid:26762262
Ueda Y et al. Interstitial cystitis associated with primary Sjögren's syndrome successfully treated with a combination of tacrolimus and corticosteroid: A case report and literature review. 2016 Mod Rheumatol pmid:24720552
Singh JA et al. Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis. 2016 J. Rheumatol. pmid:27585688
Jones-Hughes T et al. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. 2016 Health Technol Assess pmid:27578428
Saito S et al. Role of Paternal Antigen-Specific Treg Cells in Successful Implantation. 2016 Am. J. Reprod. Immunol. pmid:26706630
Herden U et al. Early Initiation of Everolimus After Liver Transplantation: A Single-Center Experience. 2016 Ann. Transplant. pmid:26842532
Thomas KS et al. Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study. 2016 J. Am. Acad. Dermatol. pmid:27502313
Yamaguchi Y et al. Plasma cell cheilitis successfully treated with topical calcineurin inhibitors. 2016 Eur J Dermatol pmid:27502182
Shuker N et al. Pretransplant Tacrolimus Dose Requirements Predict Early Posttransplant Dose Requirements in Blood Group AB0-Incompatible Kidney Transplant Recipients. 2016 Ther Drug Monit pmid:26630539
Turrión-Merino L et al. A Case Series of 4 Patients With Peristomal Pyoderma Gangrenosum: Review of Risk Factors and Treatment Response. 2016 Actas Dermosifiliogr pmid:26626501
Uemoto S et al. Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients. 2016 Clin. Exp. Immunol. pmid:26560892
Niioka T et al. Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patients. 2016 Int. J. Urol. pmid:26990259
Ogura Y et al. Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience. 2016 Ann. Transplant. pmid:27432248
Shijo T et al. A mismatch between MRI lesions and SPECT hypoperfusion in tacrolimus-related encephalopathy. 2016 J. Neurol. Sci. pmid:27423609
Asavakarn S et al. Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients. 2016 Transplant. Proc. pmid:27320587
Limsrichamrern S et al. Correlation of Hematocrit and Tacrolimus Level in Liver Transplant Recipients. 2016 Transplant. Proc. pmid:27320581
Kim JD et al. Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. 2016 Transplant. Proc. pmid:27320573
Federico S et al. Sublingual administration improves systemic exposure of tacrolimus in kidney transplant recipients: comparison with oral administration. 2016 Eur. J. Clin. Invest. pmid:27240092
Mo S et al. Improvement of FK506 Production in the High-Yielding Strain Streptomyces sp. RM7011 by Engineering the Supply of Allylmalonyl-CoA Through a Combination of Genetic and Chemical Approach. 2016 J. Microbiol. Biotechnol. pmid:26502733
Sharma P et al. Protein Phosphatase 1-α Regulates AS160 Ser588 and Thr642 Dephosphorylation in Skeletal Muscle. 2016 Diabetes pmid:27246912
Prytuła A et al. Factors associated with 1,25-dihydroxyvitamin D3 concentrations in liver transplant recipients: a prospective observational longitudinal study. 2016 Endocrine pmid:26433738
Lazelle RA et al. Renal Deletion of 12 kDa FK506-Binding Protein Attenuates Tacrolimus-Induced Hypertension. 2016 J. Am. Soc. Nephrol. pmid:26432904
Nitta D et al. Successful Pregnancy and Delivery in a Heart Transplantation Recipient. 2016 Int Heart J pmid:27150004
Jovanović M and Golušin Z Nonsteroidal Topical Immunomodulators in Allergology and Dermatology. 2016 Biomed Res Int pmid:27144167
Ban YH et al. The biosynthetic pathway of FK506 and its engineering: from past achievements to future prospects. 2016 J. Ind. Microbiol. Biotechnol. pmid:26342319
Romano C et al. Management of Acute Severe Colitis in Children With Ulcerative Colitis in the Biologics Era. 2016 Pediatrics pmid:27244779
Fujii S et al. Prior activation of inositol 1,4,5-trisphosphate receptors suppresses the subsequent induction of long-term potentiation in hippocampal CA1 neurons. 2016 Learn. Mem. pmid:27084928
Han SS et al. Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function. 2016 PLoS ONE pmid:27082871
Bianic F et al. Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting. 2016 J Med Econ pmid:27081739
Mok CC et al. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. 2016 Ann. Rheum. Dis. pmid:25550339
Ikeda M et al. Successful Second Allogeneic Stem Cell Transplantation From a Sibling Donor for Relapse of Myelodysplastic Syndrome in a Recipient of a Renal Transplant From His Mother: Case Report. 2016 Transplant. Proc. pmid:27932152
Suarez Benjumea A et al. Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. 2016 Transplant. Proc. pmid:27932111
Rodriguez Cubillo B et al. Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants. 2016 Transplant. Proc. pmid:27932117
Pallet N et al. Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype. 2016 Am. J. Transplant. pmid:26990694
Awdishu L and Joy MS Role of Pharmacogenomics in Kidney Disease and Injury. 2016 Adv Chronic Kidney Dis pmid:26979149
Stockwell J et al. Protein phosphatase role in adenosine A1 receptor-induced AMPA receptor trafficking and rat hippocampal neuronal damage in hypoxia/reperfusion injury. 2016 Neuropharmacology pmid:26626486